Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MPowrx is a private health and wellness company founded in Calgary, Alberta, Canada in 2005 by Dr. Nancy Markley. The company develops, manufactures, distributes, and markets clinically developed consumer health products, with its flagship commercial product being Good Morning Snore Solution, an FDA-cleared anti-snoring tongue-retention mouthpiece. MPowrx also markets BellyCrush, a food and snack brand built around yellow pea fiber for weight management and digestive-health positioning. The company sells internationally, reporting distribution in more than 85 countries, and operates across Canada and the United States with additional distribution in the United Kingdom and Australia. Overall, MPowrx appears to be a commercial-stage healthcare and wellness company focused on evidence-based medical device and consumer wellness products rather than a traditional drug-development biotech pipeline.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MPowrx.